coronary artery stenosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Voluntarily participate in the study and sign the informed consent; 2. Participants who participated in the ScoreFlex TRIO premarket clinical trial and were randomly enrolled.
Exclusion criteria
Exclusion criteria: 1. Subjects who meet any of the ScoreFlex TRIO exclusion criteria in premarket clinical trials; 2. Subjects with contraindications of coronary OCT examination; 3. Other cases assessed by the investigators as unsuitable for coronary OCT examination.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Minimum lumen diameter (MLD) improved;Improvement of minimum lumen diameter stenosis (MLDS);Improvement of minimum lumen area (MLA);Plaque assessment;Expansion rate of support;Bracket wall adhesion defect rate;Incidence of tissue prolapse;Incidence of stent edge dissection;Incidence of stent thrombosis; | — |
Countries
China
Contacts
Zhongshan Hospital Affiliated to Fudan University